Ritholtz Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $485K | Sell |
32,295
-11,006
| -25% | -$165K | 0.01% | 651 |
|
|
2025
Q1 | $571K | Sell |
43,301
-37,294
| -46% | -$492K | 0.02% | 559 |
|
|
2024
Q4 | $1.27M | Sell |
80,595
-6,480
| -7% | -$102K | 0.04% | 316 |
|
|
2024
Q3 | $1.38M | Buy |
87,075
+7,840
| +10% | +$125K | 0.04% | 304 |
|
|
2024
Q2 | $1.21M | Buy |
79,235
+235
| +0.3% | +$3.58K | 0.04% | 311 |
|
|
2024
Q1 | $1.16M | Buy |
79,000
+10,115
| +15% | +$148K | 0.04% | 318 |
|
|
2023
Q4 | $959K | Buy |
68,885
+16,385
| +31% | +$228K | 0.04% | 338 |
|
|
2023
Q3 | $702K | Buy |
52,500
+17,515
| +50% | +$234K | 0.03% | 373 |
|
|
2023
Q2 | $442K | Buy |
34,985
+5,060
| +17% | +$63.9K | 0.02% | 458 |
|
|
2023
Q1 | $341K | Buy |
29,925
+5,780
| +24% | +$65.8K | 0.02% | 489 |
|
|
2022
Q4 | $250K | Buy |
24,145
+3,710
| +18% | +$38.4K | 0.01% | 495 |
|
|
2022
Q3 | $214K | Sell |
20,435
-140
| -0.7% | -$1.47K | 0.01% | 638 |
|
|
2022
Q2 | $228K | Sell |
20,575
-3,725
| -15% | -$41.3K | 0.01% | 472 |
|
|
2022
Q1 | $271K | Sell |
24,300
-38,280
| -61% | -$427K | 0.02% | 435 |
|
|
2021
Q4 | $819K | Sell |
62,580
-12,410
| -17% | -$162K | 0.05% | 199 |
|
|
2021
Q3 | $977K | Sell |
74,990
-23,635
| -24% | -$308K | 0.07% | 147 |
|
|
2021
Q2 | $1.45M | Buy |
98,625
+23,320
| +31% | +$343K | 0.1% | 91 |
|
|
2021
Q1 | $925K | Buy |
75,305
+3,525
| +5% | +$43.3K | 0.08% | 116 |
|
|
2020
Q4 | $1.02M | Buy |
71,780
+6,480
| +10% | +$92.4K | 0.1% | 89 |
|
|
2020
Q3 | $908K | Buy |
65,300
+15,560
| +31% | +$216K | 0.1% | 83 |
|
|
2020
Q2 | $527K | Buy |
+49,740
| New | +$527K | 0.07% | 111 |
|